The following words and terms, when used in this subchapter, have the following meanings unless the context clearly indicates otherwise:
  (1) CEO--The superintendent of a facility.
  (2) DADS--The Department of Aging and Disability Services.
  (3) Department--The Department of Aging and Disability Services.
  (4) Facility--A state mental retardation facility operated by DADS.
  (5) Individual--A person receiving services from a facility.
  (6) LAR (legally authorized representative)--A person authorized by law to act on behalf of an individual with regard to a matter described in this subchapter and may include a parent, guardian, or managing conservator of a minor individual, a guardian of an adult individual, or a personal representative of a deceased individual.
  (7) Mental retardation--Subaverage general intellectual functioning existing concurrently with deficits in adaptive behavior and originating during the developmental period.
  (8) Material safety data sheet--The document provided by a manufacturer that describes a material's or part's chemical properties along with guidelines for proper use, storage, and disposal.
  (9) Non-commercial group--A group of people associated with an organization (for example, a civic, fraternal, religious, social, service, community, or public employee organization).
  (10) Sales receipt--A written statement issued by the seller that includes the date it was created and the cost of the item or service.
  (11) Trust fund--An account at a financial institution in a facility's control that contains funds of an individual.
  (12) Unauthorized departure that may have unusual consequences--The unauthorized departure of an individual that causes a reasonably prudent staff member who has knowledge of the individual's condition to believe that harm or injury to the individual or to others may occur as a result of the unauthorized departure, for example, the unauthorized departure of an individual whom the treatment staff believes to be a danger to self or to others or the unauthorized departure of an individual who requires maintenance medication such as insulin.

Source Note: The provisions of this §910.51 adopted to be effective June 1, 2006, 31 TexReg 4235; transferred effective July 31, 2024, as published in the July 5, 2024, issue of the Texas Register, 49 TexReg 4929